The Commonwealth Gene
Technology Regulator, Dr Sue Meek, today released for public
comment a Risk Assessment and Risk Management Plan for the Bayer
CropScience (formerly Aventis) application to commercially
release genetically modified (GM) canola throughout Australia.
The Plan has been released for an extended, eight (8) week
period of public scrutiny and comment until 26 May 2003.
"Over the past nine months I have thoroughly investigated the
possible impact of the release of seven varieties of Bayer’s
canola drawing on the expertise of a range of expert groups and
key stakeholders to assist me in my deliberations," Dr Meek
said.
"The conclusion I have reached from these exhaustive
assessments is that this GM canola poses no higher risk to human
health and safety or the environment than is currently posed by
the farming of conventional, non-genetically modified canola.
"As with the non-GM product, the genetically modified crop is
of minimal risk. Therefore, only ongoing oversight requirements
are included in the proposed licence conditions that I have set
down in the draft risk assessment and risk management plan."
Dr Meek said all of the GM canola varieties proposed by Bayer
have been previously trialled under limited and controlled
conditions in Australia and, as canola oil is used in human
food, their oils have all been assessed and approved by the
responsible food regulator, Food Standards Australia New Zealand
(FSANZ).
"I have closely examined an extensive range of possible risks
including potential for toxicity, allergenicity, gene transfer
to other crops, the likelihood of creating problem weeds and
possible impacts on wildlife and soil microorganisms but have
found no appreciable risks that would adversely affect human
health or the environment," Dr Meek said
Dr Meek said the commercial decision of whether or not to
grow GM canola is outside the scope of the Gene Technology Act
but she understood the concerns within the community about
market and trade issues posed by the introduction of GM crops in
Australia.
"There are a number of industry-focussed initiatives
proposing ways for GM and non-GM canola to co-exist and I
encourage farmers and the public to become fully informed about
all aspects of GM crops," she said.
The GM canola proposed for release by Bayer incorporates a
novel breeding system using gene technology to produce hybrid
canola varieties that will be marketed under the trade name
InVigor.
Traditional breeding techniques are used to develop hybrid
plants which display improved agronomic performance, known as
hybrid vigour, but this is the first time in Australia that
gene technology would be applied commercially to achieve the
same effect.
The Bayer canola has also been modified to incorporate
tolerance to the herbicide glufosinate ammonium which
potentially provides additional weed control options when the
crop is being grown.
Further information on the Risk Assessment and Risk
Management Plan (the final version of which will form the basis
of the Regulator’s decision on the application) is available
from the OGTR at